Efficacy and safety of the endoscopic radiofrequency ablation for unresectable cholangiocarcinoma: the pilot study

Efficacy and safety of the endoscopic radiofrequency ablation for unresectable cholangiocarcinoma: the pilot study - Efficacy and safety of the endoscopic radiofrequency ablation for unresectable cholangiocarcinoma: the pilot study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000035394

Enrollment

Registered

2018-12-28

Start date

2017-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cholangiocarcinoma

Interventions

endoscopic radiofrequency ablation

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: unresectable cholangiocarcinoma written written informed consent

Exclusion criteria

Exclusion criteria: immpossible to endoscopic approach bad general condition pregnant

Design outcomes

Primary

Measure	Time frame
technical success	—

Secondary

Measure	Time frame
survival time time to RBO complications	—

Countries

Japan

Contacts

Public ContactTakahisa Ogawa

Sendai City Medical Center Department of Gastroenterology

t-ogawa@openhp.or.jp022-252-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026